DOC logo

DOC

Healthpeak Properties

$19.73
+$0.09(+0.46%)
60
Overall
80
Value
54
Tech
47
Quality
How is this score calculated?
Market Cap
$12.89B
Volume
5.63M
52W Range
$15.70 - $19.87
Target Price
$20.06

Latest News for DOC

Morgan Stanley Sticks to Their Buy Rating for Healthpeak Properties (DOC)
TipRanks Auto-Generated Intelligence Newsdesk5 hours agoMay 22, 2026

In a report released today, Ronald Kamdem from Morgan Stanley maintained a Buy rating on Healthpeak Properties, with a price target of $20.00. Acco......

Teladoc Shareholders Approve Board, Pay and Auditor
TipRanks Auto-Generated Newsdesk21 hours agoMay 22, 2026

An update from Teladoc ( ($TDOC) ) is now available. At its 2026 Annual Meeting of Stockholders, held on May 21, 2026, Teladoc Health shareholders ......

Peel Hunt Sticks to Their Buy Rating for Dr. Martens Plc (DOCS)
TipRanks Auto-Generated Intelligence Newsdesk3 days agoMay 20, 2026

In a report released yesterday, John Stevenson from Peel Hunt maintained a Buy rating on Dr. Martens Plc. The company’s shares closed yesterday at ......

RBC Capital Sticks to Its Hold Rating for DocuSign (DOCU)
TipRanks Auto-Generated Intelligence Newsdesk3 days agoMay 20, 2026

In a report released on May 18, Rishi Jaluria from RBC Capital maintained a Hold rating on DocuSign, with a price target of $55.00. The company’s s......

DOCS, WIX, CAKE, SBUX, VRT Trending With Analysts
TipRanks Weekend Auto-Generated Newsdesk7 days agoMay 16, 2026

Analysts are intrested in these 5 stocks: ( ($DOCS) ), ( ($WIX) ), ( ($CAKE) ), ( ($SBUX) ) and ( ($VRT) ). Here is a breakdown of their recent ...

Analysts Offer Insights on Healthcare Companies: Oruka Therapeutics (ORKA), GH Research (GHRS) and Doximity (DOCS)
Brian Anderson7 days agoMay 16, 2026

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Oruka Therapeutics (ORKA), GH Research (GHRS) and Do......

RBC Capital Remains a Buy on Doximity (DOCS)
TipRanks Auto-Generated Intelligence Newsdesk7 days agoMay 16, 2026

In a report released on May 14, Ryan Halsted from RBC Capital maintained a Buy rating on Doximity, with a price target of $28.00. The company’s sha......

Teladoc (TDOC) Gets a Hold from UBS
TipRanks Auto-Generated Intelligence Newsdesk7 days agoMay 15, 2026

UBS analyst Kevin Caliendo maintained a Hold rating on Teladoc today and set a price target of $6.00. According to TipRanks, Caliendo is a 4-star a......

Doximity Earnings Call: Cash‑Rich, Slower Growth, Big AI Bet
TipRanks Auto-Generated Newsdesk8 days agoMay 15, 2026

Doximity, Inc. (($DOCS)) has held its Q4 earnings call. Read on for the main highlights of the call. Doximity’s latest earnings call painted a pict......

Why Is Doximity Stock (DOCS) Falling Today, 5/14/26?
Radhika Saraogi8 days agoMay 14, 2026

Doximity ($DOCS) shares fell 24% after the company posted mixed Q4 results and issued a weaker outlook for FY2027, which led several analysts to cu......

News data is sourced from MarketXLS API and updated regularly.
Showing 10 of 28 articles.

ABCD
1SymbolPriceChangeVol
2DOC$19.73+0.5%5.63M
3
4
5
6

Get Healthpeak Properties Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.